This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2hb3
From Proteopedia
(Difference between revisions)
| Line 20: | Line 20: | ||
==About this Structure== | ==About this Structure== | ||
| - | 2HB3 is a | + | 2HB3 is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HB3 OCA]. |
==Reference== | ==Reference== | ||
| - | + | <ref group="xtra">PMID:16913714</ref><references group="xtra"/> | |
[[Category: Chymosin]] | [[Category: Chymosin]] | ||
[[Category: Human immunodeficiency virus 1]] | [[Category: Human immunodeficiency virus 1]] | ||
| - | [[Category: Single protein]] | ||
[[Category: Kovalevsky, A Y.]] | [[Category: Kovalevsky, A Y.]] | ||
[[Category: Weber, I T.]] | [[Category: Weber, I T.]] | ||
[[Category: Active-site cavity protease inhibitor catalytic aspartic acid]] | [[Category: Active-site cavity protease inhibitor catalytic aspartic acid]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Feb 16 14:39:07 2009'' |
Revision as of 12:39, 16 February 2009
Wild-type HIV-1 Protease in complex with potent inhibitor GRL06579
Template:ABSTRACT PUBMED 16913714
About this Structure
2HB3 is a 2 chains structure of sequences from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
Reference
- Ghosh AK, Sridhar PR, Leshchenko S, Hussain AK, Li J, Kovalevsky AY, Walters DE, Wedekind JE, Grum-Tokars V, Das D, Koh Y, Maeda K, Gatanaga H, Weber IT, Mitsuya H. Structure-based design of novel HIV-1 protease inhibitors to combat drug resistance. J Med Chem. 2006 Aug 24;49(17):5252-61. PMID:16913714 doi:10.1021/jm060561m
Page seeded by OCA on Mon Feb 16 14:39:07 2009
